Journal of Crohn's and Colitis, 10(2), 149-58. Elsevier Journal of Crohn's and Colitis, 10, 2, pp. 149-58 Journal of Crohn's and Colitis, 10, 149-58 Journal of Crohn's and Colitis, 10(2), 149-158. Oxford University Press Heap, G A, So, K, Weedon, M, Edney, N, Bewshea, C, Singh, A, Annese, V, Beckly, J, Buurman, D, Chaudhary, R, Cole, A T, Cooper, S C, Creed, T, Cummings, F, de Boer, N K, D'Inca, R, D'Souza, R, Daneshmend, T K, Delaney, M, Dhar, A, Direkze, N, Dunckley, P, Gaya, D R, Gearry, R, Gore, S, Halfvarson, J, Hart, A, Hawkey, C J, Hoentjen, F, Iqbal, T, Irving, P, Lal, S, Lawrence, I, Lees, C W, Lockett, M, Mann, S, Mansfield, J, Mowat, C, Mulgrew, C J, Muller, F, Murray, C, Oram, R, Orchard, T, Parkes, M, Phillips, R, Pollok, R, Radford-Smith, G, Sebastian, S, Sen, S, Shirazi, T, Silverberg, M, Solomon, L, Sturniolo, G C, Thomas, M, Tremelling, M, Tsianos, E V, Watts, D, Weaver, S, Weersma, R K, Wesley, E, Holden, A & Ahmad, T 2016, ' Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease ', Journal of Crohn's and Colitis, vol. 10, no. 2, pp. 149-58 . https://doi.org/10.1093/ecco-jcc/jjv219